abstract |
Provided are compounds represented by formula (I) that can be used as CRTH2 receptor antagonists. The compound represented by formula (I) can be used for treating and preventing asthma, allergic rhinitis, atopic dermatitis and other diseases mediated by prostaglandin D2 (PGD2) on CRTH2 receptor. |